Evidence map›Paper›PMID 37522013›Full record

ArticleRomanian journal of ophthalmology

Choroidal neovascularization associated with butterfly-shaped pattern dystrophy - a case report.

Marta Świerczyńska, Marta Danikiewicz-Zagała, Lech Sedlak, Marta Nowak-Wąs, Dorota Wyględowska-Promieńska

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Romanian journal of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Marta ŚwierczyńskaDepartment of Ophthalmology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland.
Marta Danikiewicz-ZagałaDepartment of Ophthalmology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland.
Lech SedlakDepartment of Ophthalmology, Euromedic Hospital, Katowice, Poland.
Marta Nowak-WąsDepartment of Ophthalmology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland.
Dorota Wyględowska-PromieńskaDepartment of Ophthalmology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland.
Medical University of Silesia · PLEuromedic · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pattern dystrophies (PDs) are a group of primarily autosomal dominant inherited macular diseases that cause the deposition of lipofuscin in retinal pigment epithelium (RPE) and may lead to significant vision loss in later life. Patients can develop choroidal neovascularization (CNV) and/ or geographic atrophy (GA) and for this reason they are often misdiagnosed as age-related macular degeneration (AMD). We presented a case of a 66-year-old patient complaining of vision loss in the right eye (RE) for 8 months. At the initial examination, his best corrected visual acuity (BCVA) was 0.6 in the RE. Optical coherence tomography angiography (OCTA), fundus autofluorescence (FAF) and fundus fluorescein angiography (FFA) allowed to diagnose butterfly-shaped PD in both eyes with choroidal neovascularization (CNV) in the RE. The patient was treated with three intravitreal anti-vascular epithelial growth factor (anti-VEGF, ranibizumab) injections during six weeks intervals, which improved and stabilized the BCVA of the RE to 0.7 during the over two-year observation period. Our report contributes to the still limited data regarding CNV associated with butterfly-shaped PDs and the results of treatment with ranibizumab.

Indexed as

Choroidal NeovascularizationEye AbnormalitiesGeographic AtrophyVitelliform Macular DystrophyAdultAgedAngiogenesis InhibitorsDeafnessDiabetes Mellitus, Type 2Fluorescein AngiographyHumansIntercellular Signaling Peptides and ProteinsIntravitreal InjectionsMitochondrial DiseasesRanibizumabTomography, Optical CoherenceAngiogenesis InhibitorsIntercellular Signaling Peptides and ProteinsRanibizumabanti-VEGF treatmentbutterfly-shaped pattern dystrophychoroidal neovascularizationCNVranibizumab

Identifiers

PMID37522013
PMCPMC10385706
OpenAlexW4385271703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.